TEQCoolAB Logo

INVESTOR RELATIONS

Why invest in TEQCool?

The medical care is inevitably moving towards personalized medicine, where each patient is treated according to unique needs. Surprisingly, in spite of the great need to cool the brain to protect it when the need to reduce the brain metabolism and reduce oxygen demand becomes critical, there is no solution on the market.

A cool helmet? Does not work, the head is designed to effectively protect the brain from heat and cold applied from the outside.

Whole body cooling vest or a cooling blanket? Risks patient safety with consequences such as infections and longer hospitalization.

Mouth? Blocks breathing and not effective as too far away from the brain.

Cool the blood or inject cool liquid in the body? Cools the whole body and risks patient safety.

Nose? The nose acts as a natural heat exchanger, effectively regulating the temperature of the air before it reaches the lungs. Due to its proximity to the brain, it also helps cool the brain, as shown in studies. The large surface area and numerous blood vessels in the nasal cavities allow rapid temperature adjustment. TEQCool utilizes this natural mechanism to cool the brain without side effects from systemic cooling, requiring only 30W of power—far less than a household fridge.

TEQCool transforming neurocritical care

TEQCool is revolutionizing medical technology with its groundbreaking approach to brain temperature management. Unlike existing systems that cool the body first, our patented, non-invasive solution directly cools the brain through the nasal cavity, offering a transformative way to prevent secondary brain damage in brain injured patients such as Traumatic Brain Injury patients (TBI), Subarachnoid Hemorrhage, Status epilepticus, stroke and neonatal patients. This innovative approach has the potential to help reduce brain metabolism thereby reducing oxygen demand to the brain through heat exchange via the nasal cavities. It is poised to set a new standard of care and reshape the future of patient treatment. With our unwavering commitment to research, clinical validation, and commercialization, TEQCool presents a powerful investment opportunity in the rapidly expanding temperature management market, one that has the potential to change lives and redefine the possibilities of modern medicine.

Financial reports 2023